Aug 31 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* U.S. FDA GRANTED ORPHAN DRUG DESIGNATION FOR 4- 211AT ASTATO-L-PHENYLALANINE FOR TREATMENT OF MULTIPLE MYELOMA
Aug 31 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* U.S. FDA GRANTED ORPHAN DRUG DESIGNATION FOR 4- 211AT ASTATO-L-PHENYLALANINE FOR TREATMENT OF MULTIPLE MYELOMA